Billiontoone, Inc. revenue
Billiontoone, Inc.'s revenue was $305m in fiscal 2025, up 100.0% on the year before. Over the last twelve months it was $397m.
Revenue history
Where the revenue comes from
| Line of business | Revenue | Share | YoY |
|---|---|---|---|
| Prenatal | $277M | 90.8% | ▲ 89.9% |
| Oncology | $25M | 8.2% | ▲ 747.6% |
| Clinical Trial Support and Other Services | $3.1M | 1.0% | ▼ 18.3% |
From Billiontoone, Inc.'s 10-K filed March 11, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.
Revenue against peers
| Company | Revenue | Growth | 3-year growth a year |
|---|---|---|---|
| Billiontoone, Inc. | $397m | 90.1% | — |
| Twist Bioscience Corp | $432m | 19.2% | 22.4% |
| Castle Biosciences Inc | $357m | 3.2% | 28.7% |
| Fulgent Genetics, Inc. | $324m | 6.8% | 1.8% |
| Veracyte, Inc. | $562m | 17.3% | 19.6% |
| Schrodinger, Inc. | $259m | 8.9% | 10.2% |
Compare with peers
- Twist Bioscience Corp revenue
- Castle Biosciences Inc revenue
- Fulgent Genetics, Inc. revenue
- Veracyte, Inc. revenue
- Schrodinger, Inc. revenue
Head to head: BLLN vs TWSTBLLN vs CSTLBLLN vs FLGT
More: Life Sciences Tools & Services stocks compared, Health Care sector, rankings of US companies